GAITHERSBURG, Md.--(BUSINESS WIRE)--Calibrant Biosystems today announced the appointment of Dr. Satya Saxena as its Vice-President of Research. Dr. Saxena will lead Calibrant’s proteomic technology and product development programs. His primary focus will include expanding and validating the Gemini™ platform technology beyond the initial programs in oncology. He will also oversee the continuing drug development efforts involving lead compounds in ovarian, brain, and breast cancer.
